ArticleLife (Basel, Switzerland)2024

Factors Associated with Success of Switching to Faricimab for Neovascular Age-Related Macular Degeneration Refractory to Intravitreal Aflibercept.

Akira Machida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.